A comprehensive survey

Swarm intelligence (SI) is briefly defined as the collective behaviour of decentralized and self-organized swarms. The well known examples for these swarms are bird flocks, fish schools and the col...

[1]  Donald Lloyd-Jones,et al.  Screening for cardiovascular risk in asymptomatic patients. , 2010, Journal of the American College of Cardiology.

[2]  Subramaniam Pennathur,et al.  Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome , 2008, Circulation.

[3]  N. Paynter,et al.  C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men , 2008, Circulation.

[4]  Moyses Szklo,et al.  LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2007, Atherosclerosis.

[5]  B. Youn,et al.  Possibility-Based Design Optimization Method for Design Problems With Both Statistical and Fuzzy Input Data , 2006 .

[6]  R. Morton,et al.  Elevated Triglyceride Content Diminishes the Capacity of High Density Lipoprotein to Deliver Cholesteryl Esters via the Scavenger Receptor Class B Type I (SR-BI)* , 2001, The Journal of Biological Chemistry.

[7]  Hei Leung,et al.  Using Genetic Diversity to Achieve Sustainable Rice Disease Management. , 2003, Plant disease.

[8]  Yijun Wang,et al.  Methods for Robust Multidisciplinary Design , 2000 .

[9]  R Peto,et al.  Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. , 1991, BMJ.

[10]  Ephraim R. McLean,et al.  The DeLone and McLean Model of Information Systems Success: A Ten-Year Update , 2003, J. Manag. Inf. Syst..

[11]  Rowena J Dolor,et al.  Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.

[12]  Jackie A Cooper,et al.  A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. , 2005, Atherosclerosis.

[13]  J. S. Ivey,et al.  Nelder-Mead simplex modifications for simulation optimization , 1996 .

[14]  Kevin Otto,et al.  Manufacturing System Robustness Through Integrated Modeling , 2001 .

[15]  D K Smith,et al.  Numerical Optimization , 2001, J. Oper. Res. Soc..

[16]  Wei Chen,et al.  Towards a Better Understanding of Modeling Feasibility Robustness in Engineering Design , 2000 .

[17]  A J Dobson,et al.  Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations , 2004, Tobacco Control.

[18]  Thomas J. Santner,et al.  The Design and Analysis of Computer Experiments , 2003, Springer Series in Statistics.

[19]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[20]  Ken Nagao,et al.  Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound. , 2005, The American journal of cardiology.

[21]  James C. Spall,et al.  AN OVERVIEW OF THE SIMULTANEOUS PERTURBATION METHOD FOR EFFICIENT OPTIMIZATION , 1998 .

[22]  John W McEvoy,et al.  Coronary artery calcium progression: an important clinical measurement? A review of published reports. , 2010, Journal of the American College of Cardiology.

[23]  K. Kotseva,et al.  Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries , 2009, The Lancet.

[24]  Christopher T Sempos,et al.  Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. , 2006, The American journal of cardiology.

[25]  Christopher P Cannon,et al.  Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. , 2008, Journal of the American College of Cardiology.

[26]  Stephen Ekwaro-Osire,et al.  Life-cycle engineering: Issues, tools and research , 2003, Int. J. Comput. Integr. Manuf..

[27]  S. Yusuf,et al.  Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study , 2006, The Lancet.

[28]  Pankaj Garg,et al.  Use of the Joint British Society cardiovascular risk calculator before initiating statins for primary prevention in hospital medicine: experience from a large university teaching hospital , 2010, International journal of general medicine.

[29]  Daniel S. Berman,et al.  Asymptomatic Atherosclerosis. Pathophysiology, Detection and Treatment , 2010 .

[30]  Simon Capewell,et al.  Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. , 2009, European heart journal.

[31]  M. Lorgeril,et al.  Primary Prevention Cardiovascular Disease: Better Than Drugs—Reply , 2010 .

[32]  John E. Renaud,et al.  Reliability based design optimization using response surfaces in application to multidisciplinary systems , 2004 .

[33]  G. Getz,et al.  Paraoxonase, a cardioprotective enzyme: continuing issues , 2004, Current opinion in lipidology.

[34]  Päivi Pajukanta,et al.  Genetic causes of high and low serum HDL-cholesterol , 2010, Journal of Lipid Research.

[35]  Moyses Szklo,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[36]  Bernhard Sendhoff,et al.  Trade-Off between Performance and Robustness: An Evolutionary Multiobjective Approach , 2003, EMO.

[37]  MengChu Zhou,et al.  A life cycle engineering approach to development of flexible manufacturing systems , 2003, IEEE Trans. Robotics Autom..

[38]  Jagat Narula,et al.  Imaging vulnerable plaque by ultrasound. , 2006, Journal of the American College of Cardiology.

[39]  R. Tracy,et al.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.

[40]  Sarah Parish,et al.  The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls , 2009, European heart journal.

[41]  Michael Kinter,et al.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. , 2004, The Journal of clinical investigation.

[42]  Mark Hlatky.  The cost-effectiveness of rosuvastatin therapy JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). , 2011, Journal of the American College of Cardiology.

[43]  Elsayed Z Soliman,et al.  A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization , 2011, Trials.

[44]  Hans-Georg Beyer,et al.  A Comparison of Evolution Strategies with Other Direct Search Methods in the Presence of Noise , 2003, Comput. Optim. Appl..

[45]  Harlan M Krumholz,et al.  Exposure to low-dose ionizing radiation from medical imaging procedures. , 2009, The New England journal of medicine.

[46]  Yoshihisa Okamoto,et al.  Inflammation in atherosclerosis: transition from theory to practice. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[47]  A. Dyer,et al.  Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. , 1999, JAMA.

[48]  A. Lichtman,et al.  T cells and blood vessels: costimulation turns up the pressure. , 2010, Circulation.

[49]  F. Biancari,et al.  Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[50]  Christian W. Hamm,et al.  Calcium and C-reactive protein hot enough to predict the future? , 2011, Journal of the American College of Cardiology.

[51]  Philip Greenland,et al.  Coronary calcium scoring and cardiovascular risk: the SHAPE of things to come. , 2008, Archives of internal medicine.

[52]  Dolores E. Luna,et al.  Local government websites: cases of innovation and best practices in Mexico , 2011, dg.o '11.

[53]  Lorenzo Iughetti,et al.  Evaluation and management of hyperlipidemia in children and adolescents , 2010, Current opinion in pediatrics.

[54]  John B Buse,et al.  Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.

[55]  R. Redberg,et al.  What is the prognostic value of a zero calcium score? , 2010, Journal of the American College of Cardiology.

[56]  Usama Bilal,et al.  Challenges and opportunities for cardiovascular disease prevention. , 2011, The American journal of medicine.

[57]  Kavita Sharma,et al.  Clinical and research applications of carotid intima-media thickness. , 2009, The American journal of cardiology.

[58]  Nader Rifai,et al.  Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. , 2005, Journal of the American College of Cardiology.

[59]  Kari Sentz,et al.  Combination of Evidence in Dempster-Shafer Theory , 2002 .

[60]  Nader Rifai,et al.  Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men , 2005, Circulation.

[61]  T. Dent,et al.  Predicting the risk of coronary heart disease I. The use of conventional risk markers. , 2010, Atherosclerosis.

[62]  Bruce R. Brodie,et al.  Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis A Randomized Controlled Trial , 2004 .

[63]  Bernhard Sendhoff,et al.  Three Dimensional Aerodynamic Optimization for an Ultra-Low Aspect Ratio Transonic Turbine Stator Blade , 2005 .

[64]  A. Khera,et al.  Application of the screening for Heart Attack Prevention and Education Task Force recommendations to an urban population: observations from the Dallas Heart Study. , 2008, Archives of internal medicine.

[65]  James A Brink,et al.  Traditional clinical risk assessment tools do not accurately predict coronary atherosclerotic plaque burden: a CT angiography study. , 2009, AJR. American journal of roentgenology.

[66]  A. Khera,et al.  Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.

[67]  Harlan M. Krumholz,et al.  Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease , 2010, Annals of Internal Medicine.

[68]  Paul M. Ridker,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003 .

[69]  Olli Simell,et al.  COHORT PROFILE Cohort Profile : The STRIP Study ( Special Turku Coronary Risk Factor Intervention Project ) , an Infancy-onset Dietary and Life-style Intervention Trial , 2009 .

[70]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[71]  P Langenberg,et al.  Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. , 2001, Archives of internal medicine.

[72]  Clyde W Yancy.  Transformation of cardiovascular health: presidential address at the American Heart Association 2009 scientific sessions. , 2010, Circulation.

[73]  Ilan Gottlieb,et al.  The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. , 2010, Journal of the American College of Cardiology.

[74]  Nicholas J Wareham,et al.  Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. , 2007, Journal of the American College of Cardiology.

[75]  T. Dayspring,et al.  Moving beyond LDL-C: incorporating lipoprotein particle numbers and geometric parameters to improve clinical outcomes , 2010 .

[76]  S. Griffin,et al.  International Diabetes Federation: An update of the evidence concerning the prevention of type 2 diabetes. , 2010, Diabetes research and clinical practice.

[77]  Paolo Raggi,et al.  Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. , 2005, Journal of the American College of Cardiology.

[78]  Shah Ebrahim,et al.  Statins for the primary prevention of cardiovascular disease (Review) , 2011 .

[79]  Wei Chen,et al.  Utility of Childhood Glucose Homeostasis Variables in Predicting Adult Diabetes and Related Cardiometabolic Risk Factors , 2009, Diabetes Care.

[80]  G Rose,et al.  Sick individuals and sick populations. , 1985, International journal of epidemiology.

[81]  S. D. de Ferranti,et al.  Storm over statins--the controversy surrounding pharmacologic treatment of children. , 2008, The New England journal of medicine.

[82]  Ali M. Al Khouri.  An Innovative Approach for E-Government Transformation , 2011 .

[83]  M. Woodward,et al.  Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) , 2005, Heart.

[84]  Harish Agarwal,et al.  Reliability Based Design Optimization: Formulations and Methodologies , 2004 .

[85]  N. Cook,et al.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.

[86]  Stephen S. Lim,et al.  High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries. , 2011, Bulletin of the World Health Organization.

[87]  Kwon-Hee Lee,et al.  Robust optimization considering tolerances of design variables , 2001 .

[88]  Wiley Chan,et al.  Intensity of lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment among the elderly before and after the 2004 National Cholesterol Education Program Adult Treatment Panel III update. , 2007, American heart journal.

[89]  Paul Schoenhagen,et al.  Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol. , 2010, Journal of the American College of Cardiology.

[90]  Wu Li,et al.  Options for Robust Airfoil Optimization under Uncertainty , 2002 .

[91]  M. Papadrakakis,et al.  Multi-objective design optimization using cascade evolutionary computations , 2005 .

[92]  R. Detrano,et al.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2005, Radiology.

[93]  Paul M Ridker,et al.  Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). , 2011, Journal of the American College of Cardiology.

[94]  Amanda Sacker,et al.  Impact of Coronary Heart Disease on Health Functioning in an Aging Population: Are There Differences According to Socioeconomic Position? , 2008, Psychosomatic medicine.

[95]  Byung Chai Lee,et al.  Development of a simple and efficient method for robust optimization , 2002 .

[96]  S. Ward,et al.  A systematic review and economic evaluation of statins for the prevention of coronary events. , 2007, Health technology assessment.

[97]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[98]  Tim D. Spector,et al.  Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic Influences , 2004, Circulation.

[99]  Bruce M Psaty,et al.  Primary prevention of cardiovascular disease: time to get more or less personal? , 2009, JAMA.

[100]  S. Ranji Ranjithan,et al.  Chance-constrained genetic algorithms , 1999 .

[101]  A. Rollins,et al.  Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. , 2009, JACC. Cardiovascular interventions.

[102]  Robert L Wilensky,et al.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.

[103]  Jan J Piek,et al.  Arteriogenesis requires toll-like receptor 2 and 4 expression in bone-marrow derived cells. , 2011, Journal of molecular and cellular cardiology.

[104]  James R. Wilson,et al.  A revised simplex search procedure for stochastic simulation response-surface optimization , 1998, WSC '98.

[105]  Z. Mourelatos,et al.  A Design Optimization Method Using Evidence Theory , 2006, DAC 2005.

[106]  Peter Libby,et al.  Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.

[107]  Mika Kähönen,et al.  Association of Pathobiologic Determinants of Atherosclerosis in Youth risk score and 15-year change in risk score with carotid artery intima-media thickness in young adults (from the Cardiovascular Risk in Young Finns Study). , 2007, The American journal of cardiology.

[108]  Josef Makolm,et al.  Best Practice in e-Government , 2002, EGOV.

[109]  Adrian Hernandez,et al.  Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. , 2009, American heart journal.

[110]  Zissimos P. Mourelatos,et al.  A Methodology for Trading-Off Performance and Robustness Under Uncertainty , 2006, DAC 2005.

[111]  Daniel Bloomfield,et al.  Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients. , 2009, American heart journal.

[112]  Jay D. Martin,et al.  A Monte Carlo Method for Reliability-Based Design Opitmization , 2006 .

[113]  Feng Lin,et al.  Nonoptimal Lipids Commonly Present in Young Adults and Coronary Calcium Later in Life: The CARDIA (Coronary Artery Risk Development in Young Adults) Study , 2010, Annals of Internal Medicine.

[114]  Gyung-Jin Park,et al.  Robust optimization of an automobile rearview mirror for vibration reduction , 2001 .

[115]  Peter M Nilsson,et al.  ACCORD and Risk-Factor Control in Type 2 Diabetes. , 2010, The New England journal of medicine.

[116]  Christopher P Cannon,et al.  Safety of anacetrapib in patients with or at high risk for coronary heart disease. , 2010, The New England journal of medicine.

[117]  Jin-Su Kang,et al.  Robust economic optimization of process design under uncertainty , 2004 .

[118]  G. Geoffrey Vining,et al.  Taguchi's parameter design: a panel discussion , 1992 .

[119]  Kirsten Bibbins-Domingo,et al.  Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering , 2009, Annals of Internal Medicine.

[120]  E. Ford,et al.  Trends in obesity and abdominal obesity among adults in the United States from 1999–2008 , 2011, International Journal of Obesity.

[121]  J. Ayer,et al.  Placing the cardiovascular risk of childhood obesity in perspective , 2010, International Journal of Obesity.

[122]  Robert J Glynn,et al.  Alcohol Consumption and Plasma Concentration of C-Reactive Protein , 2003, Circulation.

[123]  Emily M. Zechman,et al.  An evolutionary algorithm to generate alternatives (EAGA) for engineering optimization problems , 2004 .

[124]  Paul M. Ridker,et al.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. , 2001, The New England journal of medicine.

[125]  R. J. Hamilton,et al.  A technique for optimally designing fibre-reinforced laminated plates with manufacturing uncertainties for maximum buckling strength , 2005 .

[126]  E. Tuzcu,et al.  Coronary atherosclerosis can regress with very intensive statin therapy. , 2006, Cleveland Clinic journal of medicine.

[127]  Marco Tomassini,et al.  Using Genetic Algorithms For Robust Optimization In Financial Applications , 1998 .

[128]  Gary S. Mintz,et al.  EVEN AFTER PERCUTANEOUS CORONARY INTERVENTION OF ANGIOGRAPHICALLY SIGNIFICANT LESIONS, IVUS-DEFINED HIGH-GRADE STENOSES ARE COMMON. A BASELINE IVUS ANALYSIS FROM THE PROSPECT TRIAL , 2010 .

[129]  Thomas Bäck,et al.  Evolutionary computation: comments on the history and current state , 1997, IEEE Trans. Evol. Comput..

[130]  Prashant C. Palvia,et al.  Developing and validating an instrument for measuring user-perceived web quality , 2002, Inf. Manag..

[131]  John A Wagner,et al.  Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies , 2007, The Lancet.

[132]  Farrokh Mistree,et al.  Robust Design of Cellular Materials With Topological and Dimensional Imperfections , 2006 .

[133]  D. Rader,et al.  When HDL gets fat... , 2008, Circulation research.

[134]  H. Tse,et al.  Utilization of lipid lowering medications among adults in the United States 1999-2006. , 2010, Atherosclerosis.

[135]  Jeremiah R. Brown,et al.  Coronary heart disease and prevention in the United States. , 2010, The New England journal of medicine.

[136]  M. Pencina,et al.  Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. , 2009, JAMA.

[137]  Tina Costacou,et al.  Adherence to a Mediterranean diet and survival in a Greek population. , 2003, The New England journal of medicine.

[138]  Robert J. Vanderbei,et al.  Robust Optimization of Large-Scale Systems , 1995, Oper. Res..

[139]  Christopher P Cannon,et al.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.

[140]  Enrico Vassallo,et al.  Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. , 2010, Journal of the American College of Cardiology.

[141]  Melvyn Sim,et al.  The Price of Robustness , 2004, Oper. Res..

[142]  Wojciech Zareba,et al.  Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation. , 2006, Atherosclerosis.

[143]  Samia Mora,et al.  Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women , 2009, Circulation.

[144]  Salim Yusuf,et al.  Lipid lowering for primary prevention , 2009, The Lancet.

[145]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[146]  Jean-Louis Martin,et al.  Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction Final Report of the Lyon Diet Heart Study , 1999 .

[147]  G. Lewis,et al.  Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. , 2003, Clinical biochemistry.

[148]  Hans-Paul Schwefel,et al.  Evolution strategies – A comprehensive introduction , 2002, Natural Computing.

[149]  M. Caulfield,et al.  Effects of torcetrapib in patients at high risk for coronary events. , 2007, The New England journal of medicine.

[150]  J. Mulvey,et al.  Making a case for robust optimization models , 1997 .

[151]  Michel Jeanjean,et al.  Obstacles to cardiovascular prevention in general practice , 2004, Acta cardiologica.

[152]  A. Mills,et al.  Patient perceptions of computed tomographic imaging and their understanding of radiation risk and exposure. , 2011, Annals of emergency medicine.

[153]  Sridevi Devaraj,et al.  C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes. , 2009, Clinical chemistry.

[154]  Christopher B. Kendall,et al.  Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[155]  Richard M. Moe,et al.  Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. , 2004, Journal of the American College of Cardiology.

[156]  K. Ishii,et al.  DESIGN OPTIMIZATION FOR ROBUSTNESS USING QUADRATURE FACTORIAL MODELS , 1998 .

[157]  C. Mantzoros,et al.  Adiponectin in insulin resistance: lessons from translational research. , 2010, The American journal of clinical nutrition.

[158]  Georg Endler,et al.  C-reactive protein and all-cause mortality in a large hospital-based cohort. , 2008, Clinical chemistry.

[159]  Simon Capewell,et al.  Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000. , 2009, American journal of epidemiology.

[160]  Alfred J. Tuchfarber,et al.  Public perception of stroke warning signs and knowledge of potential risk factors. , 1998, JAMA.

[161]  Damini Dey,et al.  Not all body fat weighs equally in the acceleration of coronary artery disease. , 2010, JACC. Cardiovascular imaging.

[162]  Shabbir Ahmed,et al.  On robust optimization of two-stage systems , 2004, Math. Program..

[163]  A. Gotto,et al.  Improving lipid goal attainment: is it enough? , 2009, Circulation.

[164]  Bernhard Sendhoff,et al.  On the Impact of Systematic Noise on the Evolutionary Optimization Performance—A Sphere Model Analysis , 2004, Genetic Programming and Evolvable Machines.

[165]  S. Gidding,et al.  Assembling evidence to justify prevention of atherosclerosis beginning in youth. , 2010, Circulation.

[166]  B. Ansell,et al.  Targeting the anti-inflammatory effects of high-density lipoprotein. , 2007, The American journal of cardiology.

[167]  J. Crouse,et al.  and media thickness progression ? The METEOR study − placebo on carotid intima media thickness modify the effect of rosuvastatin when compared with − Does baseline carotid intima , 2010 .

[168]  Mario J. Garcia,et al.  An ounce of prevention with a calcium score scan? , 2009, JACC. Cardiovascular imaging.

[169]  Lu Tian,et al.  Predicting cardiovascular risk: so what do we do now? , 2006, Archives of Internal Medicine.

[170]  Erik K. Antonsson,et al.  Design parameter selection in the presence of noise , 1994 .

[171]  H. Robbins.  A Stochastic Approximation Method , 1951 .

[172]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[173]  Farrokh Mistree,et al.  An Approach to Robust Design of Turbulent Convective Systems , 2006 .

[174]  W. Kannel,et al.  Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. , 1982, American heart journal.

[175]  R. D'Agostino,et al.  Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups , 2006, Heart.

[176]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[177]  Robert S. Rosenson,et al.  Effects of Rosuvastatin and Atorvastatin on Low-Density and High-Density Lipoprotein Particle Concentrations in Patients With Metabolic Syndrome: A Randomized, Double-Blind, Controlled Study , 2009 .

[178]  Shigeyoshi Tsutsui,et al.  A Robust Solution Searching Scheme in Genetic Search , 1996, PPSN.

[179]  Rafael Perera,et al.  Lipid re-screening: what is the best measure and interval? , 2009, Heart.

[180]  Genichi Taguchi,et al.  Quality Engineering through Design Optimization , 1989 .

[181]  B. Nordestgaard,et al.  Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study. , 2003, Journal of the American College of Cardiology.

[182]  Stephen Balter,et al.  Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. , 2010, JAMA.

[183]  J. Weissenbach,et al.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.

[184]  John Abramson,et al.  Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal. , 2010, Archives of internal medicine.

[185]  Phil Husbands,et al.  A Comparison of Search Techniques on a Wing-Box Optimisation Problem , 1996, PPSN.

[186]  P. Papalambros,et al.  Monotonicity and active set strategies in probabilistic design optimization , 2006 .

[187]  Bin Liu,et al.  The Metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort Study‐CVD , 2009, Clinical endocrinology.

[188]  G. Boden,et al.  Endoplasmic Reticulum Stress: Another Link Between Obesity and Insulin Resistance/Inflammation? , 2009, Diabetes.

[189]  T. Dent,et al.  Predicting the risk of coronary heart disease. II: the role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction. , 2010, Atherosclerosis.

[190]  Dorairaj Prabhakaran,et al.  Educational status and cardiovascular risk profile in Indians , 2007, Proceedings of the National Academy of Sciences.

[191]  Murray Stewart,et al.  Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[192]  Tracey McLaughlin,et al.  Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. , 2007, Archives of internal medicine.

[193]  Dan Ryan,et al.  Cholesteryl Ester Transfer Protein Polymorphism (TaqIB) Associates With Risk in Postinfarction Patients With High C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[194]  Prakash Deedwania,et al.  Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease: Results of the Study Assessing Goals in the Elderly (SAGE) , 2007, Circulation.

[195]  Thomas P. Erlinger,et al.  Smoking Cessation and Cardiovascular Disease Risk Factors: Results from the Third National Health and Nutrition Examination Survey , 2005, PLoS medicine.

[196]  Steve Drew,et al.  The Effects of Website Quality on Adoption of E-Government Service: AnEmpirical Study Applying UTAUT Model Using SEM , 2012, ArXiv.

[197]  Michael C. Ferris,et al.  A Direct Search Algorithm for Optimization with Noisy Function Evaluations , 2000, SIAM J. Optim..

[198]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[199]  Morten Goodwin Olsen,et al.  Benchmarking e-Government - A Comparative Review of Three International Benchmarking Studies , 2009, 2009 Third International Conference on Digital Society.

[200]  P. O'Malley,et al.  A double take on serial measurement of coronary artery calcification. , 2009, Archives of internal medicine.

[201]  J. Forrester,et al.  Redefining normal low-density lipoprotein cholesterol: a strategy to unseat coronary disease as the nation's leading killer. , 2010, Journal of the American College of Cardiology.

[202]  Yaochu Jin,et al.  A comprehensive survey of fitness approximation in evolutionary computation , 2005, Soft Comput..

[203]  Y. Ozaki,et al.  Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[204]  Hans-Georg Beyer,et al.  On the Effects of Outliers on Evolutionary Optimization , 2003, IDEAL.

[205]  Wei Chen,et al.  Quality utility : a Compromise Programming approach to robust design , 1999 .

[206]  Bernhard Sendhoff,et al.  Trusted Evolutionary Algorithm , 2006, 2006 IEEE International Conference on Evolutionary Computation.

[207]  A. Kontush,et al.  Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis , 2006, Pharmacological Reviews.

[208]  H. Szajewska,et al.  Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials , 2010, Archives of Disease in Childhood.

[209]  Mauricio Solar,et al.  Capability Maturity Framework for eGovernment: A Multi-dimensional Model and Assessing Tool , 2008, EGOV.

[210]  R. Redberg,et al.  Cancer risks and radiation exposure from computed tomographic scans: how can we be sure that the benefits outweigh the risks? , 2009, Archives of internal medicine.

[211]  Simon Capewell,et al.  Optimal cardiovascular prevention strategies for the 21st century. , 2010, JAMA.

[212]  Kevin M. Johnson,et al.  The detection of any coronary calcium outperforms Framingham risk score as a first step in screening for coronary atherosclerosis. , 2010, AJR. American journal of roentgenology.

[213]  R. Krauss,et al.  Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel , 2006, Journal of internal medicine.

[214]  David B. Fogel,et al.  Evolving artificial intelligence , 1992 .

[215]  Harlan M Krumholz,et al.  Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. , 2010, Journal of the American College of Cardiology.

[216]  David Hemenway,et al.  Why we don't spend enough on public health. , 2010, The New England journal of medicine.

[217]  Gary Shaw,et al.  Interleukin-1 Regulates Multiple Atherogenic Mechanisms in Response to Fat Feeding , 2009, PloS one.

[218]  David E. Goldberg,et al.  Genetic Algorithms in Search Optimization and Machine Learning , 1988 .

[219]  Udo Hoffmann,et al.  Parental Occurrence of Premature Cardiovascular Disease Predicts Increased Coronary Artery and Abdominal Aortic Calcification in the Framingham Offspring and Third Generation Cohorts , 2007, Circulation.

[220]  A. Go,et al.  Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate- and Low-Cardiovascular-Risk Individuals for Statin Therapy , 2010, Circulation.

[221]  Carl D. Sorensen,et al.  A general approach for robust optimal design , 1993 .

[222]  Richard Kones,et al.  Low-fat versus low-carbohydrate diets, weight loss, vascular health, and prevention of coronary artery disease: the evidence, the reality, the challenge, and the hope. , 2010, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[223]  Sridevi Devaraj,et al.  Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. , 2009, Clinical chemistry.

[224]  N. Weinstein.  Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample , 1987, Journal of Behavioral Medicine.

[225]  C Di Mario,et al.  Discrepancy between angiography and intravascular ultrasound when analysing small coronary arteries. , 2002, European heart journal.

[226]  Xu Changwen,et al.  Fuzzy optimization of structures by the two-phase method , 1989 .

[227]  J Wouter Jukema,et al.  Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. , 2010, Archives of internal medicine.

[228]  Philip Greenland,et al.  Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry). , 2007, The American journal of cardiology.

[229]  K. Ferdinand,et al.  Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. , 2004, Clinical therapeutics.

[230]  Ralph D'Agostino,et al.  Risk Prediction in Cardiovascular Medicine Cardiovascular Risk-Estimation Systems in Primary Prevention Do They Differ ? Do They Make a Difference ? Can We See the Future ? , 2010 .

[231]  A Lawrence Gould,et al.  Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib. , 2009, American heart journal.

[232]  Indraneel Das,et al.  ROBUSTNESS OPTIMIZATION FOR CONSTRAINED NONLINEAR PROGRAMMING PROBLEMS , 2000 .

[233]  Rebecca S Lewis,et al.  Projected cancer risks from computed tomographic scans performed in the United States in 2007. , 2009, Archives of internal medicine.

[234]  Jesús Millán Núñez-Cortés,et al.  Estudio REALIST (REsiduAl risk, LIpids and Standard Therapies): Un análisis del Riesgo Residual dependiente del perfil lipídico en el síndrome coronario agudo , 2011 .

[235]  June Stevens,et al.  Commentary: obesity claims and controversies. , 2006, International journal of epidemiology.

[236]  Michael J Pencina,et al.  LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. , 2007, Journal of clinical lipidology.

[237]  D. Williamson,et al.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence , 2010, Population health metrics.

[238]  E. Mahoney,et al.  Targeting patients for statin therapy for the primary prevention of vascular events: what is the best approach? , 2010, Circulation.

[239]  Gordon H Guyatt,et al.  Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis , 2009, BMJ : British Medical Journal.

[240]  John R. Koza,et al.  Genetic programming - on the programming of computers by means of natural selection , 1993, Complex adaptive systems.

[241]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[242]  Daniel S Berman,et al.  Coronary artery calcium as a measure of biologic age. , 2006, Atherosclerosis.

[243]  Muredach P. Reilly,et al.  Inflammation Impairs Reverse Cholesterol Transport In Vivo , 2009, Circulation.

[244]  Timothy M. Cameron,et al.  Robust design optimization of structures through consideration of variation , 2002 .

[245]  J. Hippisley-Cox,et al.  Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study , 2007, BMJ : British Medical Journal.

[246]  Hayden B. Bosworth,et al.  Challenges and strategies to improve patient health literacy and competencies , 2010 .

[247]  Daniel S Berman,et al.  Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal? , 2010, Journal of the American College of Cardiology.

[248]  I. Doltsinis,et al.  ROBUST DESIGN OF STRUCTURES USING OPTIMIZATION METHODS , 2004 .

[249]  L Sam Lewis.  The CASE for fire and forget , 2008, BMJ : British Medical Journal.

[250]  J. Dietschy,et al.  Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 , 2004, Journal of Lipid Research.

[251]  Panos Y. Papalambros,et al.  A Bayesian Approach to Reliability-Based Optimization With Incomplete Information , 2006, DAC 2006.

[252]  Steven Hawken,et al.  Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study , 2008, The Lancet.

[253]  Arkadi Nemirovski,et al.  Robust Convex Optimization , 1998, Math. Oper. Res..

[254]  John S. Hill,et al.  Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. , 2010, Journal of the American College of Cardiology.

[255]  Markus Perola,et al.  An Immune Response Network Associated with Blood Lipid Levels , 2010, PLoS genetics.

[256]  Renke Maas,et al.  Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome. , 2007, International journal of cardiology.

[257]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[258]  Jacek Marczyk,et al.  Stochastic multidisciplinary improvement - Beyond optimization , 2000 .

[259]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[260]  B. G. Brown,et al.  Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials , 2006, Current opinion in lipidology.

[261]  G. Bray,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2583–2589 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2004-0535 Medical Consequences of Obesity , 2022 .

[262]  R H Selzer,et al.  Serial quantitative coronary angiography and coronary events. , 2000, American heart journal.

[263]  C. Lavie,et al.  Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. , 2009, Journal of the American College of Cardiology.

[264]  David E. Goldberg,et al.  The Design of Innovation: Lessons from and for Competent Genetic Algorithms , 2002 .

[265]  Philip A Kern,et al.  Adipocytokines and the metabolic complications of obesity. , 2008, The Journal of clinical endocrinology and metabolism.

[266]  Melvyn Sim,et al.  Robust Discrete Optimization , 2003 .

[267]  Michael S. Lauer,et al.  Screening asymptomatic subjects for subclinical atherosclerosis: not so obvious. , 2010, Journal of the American College of Cardiology.

[268]  S. Reddy,et al.  A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. , 2001, Journal of lipid research.

[269]  D. Giugliano,et al.  Diet and inflammation: a link to metabolic and cardiovascular diseases. , 2006, European heart journal.

[270]  I. Graham,et al.  Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. , 2009, Journal of the American College of Cardiology.

[271]  Christopher P Cannon,et al.  High-density lipoprotein and coronary heart disease: current and future therapies. , 2010, Journal of the American College of Cardiology.

[272]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[273]  P. Ridker,et al.  Inflammatory bio‐markers and cardiovascular risk prediction , 2002, Journal of internal medicine.

[274]  Arkadi Nemirovski,et al.  Robust optimization – methodology and applications , 2002, Math. Program..

[275]  Alice Stanton,et al.  Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study , 2005, Hypertension.

[276]  Pierre Amarenco,et al.  Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. , 2010, Atherosclerosis.

[277]  A. Kontush,et al.  Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors , 2009, European heart journal.

[278]  Risto Telama,et al.  Life-time risk factors and progression of carotid atherosclerosis in young adults: the Cardiovascular Risk in Young Finns study. , 2010, European heart journal.

[279]  Angela Cooper,et al.  Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance , 2008, BMJ : British Medical Journal.

[280]  Carey N. Lumeng,et al.  T-ing up inflammation in fat , 2009, Nature Medicine.

[281]  C. Kawas,et al.  High Levels of Serum C‐Reactive Protein Are Associated with Greater Risk of All‐Cause Mortality, but Not Dementia, in the Oldest‐Old: Results from The 90+ Study , 2009, Journal of the American Geriatrics Society.

[282]  H. O. Posten.  Multidimensional Gaussian Distributions , 1964 .

[283]  Michael Aviram,et al.  Paraoxonases role in the prevention of cardiovascular diseases , 2009, BioFactors.

[284]  C. Monaco,et al.  Innate immunity meets arteriogenesis: the versatility of toll-like receptors. , 2011, Journal of molecular and cellular cardiology.

[285]  Harlan M Krumholz,et al.  Use of medical imaging procedures with ionizing radiation in children: a population-based study. , 2011, Archives of pediatrics & adolescent medicine.

[286]  Horst Greiner.  Robust filter design by stochastic optimization , 1994, Other Conferences.

[287]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[288]  Olli Saarela,et al.  Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts: The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project , 2010, Circulation.

[290]  Melvyn Sim,et al.  Robust discrete optimization and network flows , 2003, Math. Program..

[291]  S. Yusuf,et al.  Stemming the global tsunami of cardiovascular disease , 2011, The Lancet.

[292]  C. Yancy,et al.  Is ideal cardiovascular health attainable? , 2011, Circulation.

[293]  Haoyu Wang,et al.  Safety Envelope for Load Tolerance and its Application to Fatigue Reliability Design , 2006 .

[294]  Moyses Szklo,et al.  Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2008, Archives of internal medicine.

[295]  A. Neumaier,et al.  A grid algorithm for bound constrained optimization of noisy functions , 1995 .

[296]  Bernhard Sendhoff,et al.  Three dimensional evolutionary aerodynamic design optimization with CMA-ES , 2005, GECCO '05.

[297]  M. Domanski,et al.  Primary prevention of coronary artery disease. , 2007, The New England journal of medicine.

[298]  Hiroto Utsunomiya,et al.  Association between visceral adipose tissue area and coronary plaque morphology assessed by CT angiography. , 2010, JACC. Cardiovascular imaging.

[299]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[300]  Mary Barton,et al.  Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement , 2010, Pediatrics.

[301]  John P A Ioannidis,et al.  What makes a good predictor?: the evidence applied to coronary artery calcium score. , 2010, JAMA.

[302]  Terence Dwyer,et al.  Factors affecting the stability of blood lipid and lipoprotein levels from youth to adulthood: evidence from the Childhood Determinants of Adult Health Study. , 2011, Archives of pediatrics & adolescent medicine.

[303]  Thomas Bäck,et al.  Robust design of multilayer optical coatings by means of evolutionary algorithms , 1998, IEEE Trans. Evol. Comput..

[304]  Richard Kones,et al.  Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention , 2011, Therapeutic advances in cardiovascular disease.

[305]  Sunita Dodani,et al.  Is HDL function as important as HDL quantity in the coronary artery disease risk assessment? , 2009, Journal of clinical lipidology.

[306]  P. Greenland,et al.  Coronary artery calcium score and risk classification for coronary heart disease prediction. , 2010, JAMA.

[307]  Paul Schoenhagen,et al.  Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. , 2007, JAMA.

[308]  Raimund Erbel,et al.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. , 2006, JAMA.

[309]  M. J. Moon.  The Evolution of E-Government among Municipalities: Rhetoric or Reality? , 2002 .

[310]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[311]  J. Spall.  Stochastic Optimization, Stochastic Approximation and Simulated Annealing , 1999 .

[312]  Costantina Manes,et al.  Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy , 2010, Circulation.

[313]  Elisavet H. Fotiadou,et al.  HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. , 2010, Atherosclerosis.

[314]  Morteza Naghavi,et al.  Legislating screening for atherosclerosis. , 2008, Journal of the American Medical Association (JAMA).

[315]  Carl E Orringer,et al.  The absence of coronary calcium: clinical and therapeutic implications for the clinical lipidologist. , 2010, Journal of clinical lipidology.

[316]  Efthimios Tambouris,et al.  An Overview of DC-Based e-Government Metadata Standards and Initiatives , 2004, EGOV.

[317]  Ahmad Esmaillzadeh,et al.  Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. , 2006, The American journal of clinical nutrition.

[318]  J. Spertus,et al.  resident ’ s Page : Employing Shared Decision-aking Models to Improve Care and Patient alue : A Cardiovascular Professional Initiative , 2022 .

[319]  John H. Holland,et al.  Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .

[320]  Jean-Claude Tardif,et al.  Effect of torcetrapib on the progression of coronary atherosclerosis. , 2007, The New England journal of medicine.

[321]  H. Brewer,et al.  New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport. , 2003, The American journal of cardiology.

[322]  Børge G Nordestgaard,et al.  Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial , 2009, The Lancet.

[323]  Jungwoo Lee,et al.  Developing fully functional E-government: A four stage model , 2001, Gov. Inf. Q..

[324]  Steven E. Nissen,et al.  High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults: Evidence From Intravascular Ultrasound , 2001, Circulation.

[325]  Sigrún Andradóttir,et al.  A review of simulation optimization techniques , 1998, 1998 Winter Simulation Conference. Proceedings (Cat. No.98CH36274).

[326]  U. Laufs,et al.  Strategies to improve drug adherence. , 2011, European heart journal.

[327]  Susan L. Albin,et al.  Robust Optimization of Experimentally Derived Objective Functions , 2003 .

[328]  Brahmajee K Nallamothu,et al.  Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis. , 2010, American heart journal.

[329]  Sarah Lord,et al.  When Is Measuring Sensitivity and Specificity Sufficient To Evaluate a Diagnostic Test, and When Do We Need Randomized Trials? , 2006, Annals of Internal Medicine.

[330]  N. Wong,et al.  Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. , 2008, American heart journal.

[331]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[332]  C. Lavie,et al.  Efficacy and safety of intensive statin therapy in the elderly. , 2008, The American journal of geriatric cardiology.

[333]  Tapabrata Ray,et al.  A surrogate assisted parallel multiobjective evolutionary algorithm for robust engineering design , 2006 .

[334]  Nicholas J Wald,et al.  The polypill concept , 2010, Postgraduate Medical Journal.

[335]  Robert Dufour,et al.  Canadian Cardiovascular Society / Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations , 2009 .

[336]  R. D'Agostino,et al.  Increased Small Low-Density Lipoprotein Particle Number: A Prominent Feature of the Metabolic Syndrome in the Framingham Heart Study , 2005, Circulation.

[337]  Katsumi Miyauchi,et al.  Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin , 2009, Journal of the American College of Cardiology.

[338]  Ricardo Uauy,et al.  Obesity indicators and cardiometabolic status in 4-y-old children. , 2010, The American journal of clinical nutrition.

[339]  Curt D. Furberg,et al.  Coronary Heart Disease in Patients With Low LDL-Cholesterol Benefit of Pravastatin in Diabetics and Enhanced Role for HDL-Cholesterol and Triglycerides as Risk Factors , 2002 .

[340]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[341]  Daniel Steinberg,et al.  Earlier intervention in the management of hypercholesterolemia: what are we waiting for? , 2010, Journal of the American College of Cardiology.

[342]  A. Gotto,et al.  Statin therapy and the elderly: SAGE advice? , 2007, Circulation.

[343]  John Hickner,et al.  Family physician's knowledge, beliefs, and self-reported practice patterns regarding hyperlipidemia: a National Research Network (NRN) survey. , 2006, Journal of the American Board of Family Medicine : JABFM.

[344]  E. McGlynn,et al.  The quality of health care delivered to adults in the United States. , 2003, The New England journal of medicine.

[345]  M. Davidson,et al.  Apolipoprotein A-I therapy promise, challenges, and disappointment. , 2011, Journal of the American College of Cardiology.

[346]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[347]  Massimo Midiri,et al.  Coronary calcium score and computed tomography coronary angiography in high-risk asymptomatic subjects: assessment of diagnostic accuracy and prevalence of non-obstructive coronary artery disease , 2009, European Radiology.

[348]  J. Pippin,et al.  Primary prevention cardiovascular disease: better than drugs. , 2010, Archives of internal medicine.

[349]  Horst Treiblmaier,et al.  What Keeps the E-Banking Customer Loyal? A Multigroup Analysis of the Moderating Role of Consumer Characteristics on E-Loyalty in the Financial Service Industry. , 2006 .

[350]  Alexander Tsertsvadze,et al.  Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia , 2009, Annals of Internal Medicine.

[351]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[352]  Jan J Piek,et al.  A critical review of clinical arteriogenesis research. , 2009, Journal of the American College of Cardiology.

[353]  Hermann Brenner,et al.  Effect of alcohol consumption on systemic markers of inflammation , 2001, The Lancet.

[354]  Ralph D'Agostino,et al.  Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors , 2005, Annals of Internal Medicine.

[355]  Ralph B D'Agostino,et al.  Framingham risk score and prediction of lifetime risk for coronary heart disease. , 2004, The American journal of cardiology.

[356]  Iftikhar J. Kullo,et al.  Early identification of cardiovascular risk using genomics and proteomics , 2010, Nature Reviews Cardiology.

[357]  Victor M. Montori,et al.  Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion , 2008, The Journal of clinical endocrinology and metabolism.

[358]  Stephane Heritier,et al.  Monitoring Cholesterol Levels: Measurement Error or True Change? , 2008, Annals of Internal Medicine.

[359]  J. Stein,et al.  Carotid intima-media thickness, plaques, and cardiovascular disease risk: implications for preventive cardiology guidelines. , 2010, Journal of the American College of Cardiology.

[360]  W. Lewis,et al.  Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis. , 2010, Preventive cardiology.

[361]  Eric Boerwinkle,et al.  Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. , 2010, Journal of the American College of Cardiology.

[362]  Peter Libby,et al.  Inflammation in Atherosclerosis : From Vascular Biology to Biomarker Discovery and Risk Prediction , 2007 .

[363]  Hirofumi Anno,et al.  Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. , 2010, JACC. Cardiovascular imaging.

[364]  J. Kastelein,et al.  Controversies in cardiovascular medicine C-reactive protein is a mediator of cardiovascular disease , 2010 .

[365]  R. Rackwitz.  Reliability analysis—a review and some perspectives , 2001 .

[366]  M Alan Brookhart,et al.  Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[367]  Varghese George,et al.  Can dysfunctional HDL explain high coronary artery disease risk in South Asians? , 2008, International journal of cardiology.

[368]  Andy J. Keane,et al.  Robust Design of Compressor Fan Blades Against Erosion , 2006 .

[369]  Eduardo Esteve,et al.  Dyslipidemia and inflammation: an evolutionary conserved mechanism. , 2005, Clinical nutrition.

[370]  M L Garg,et al.  SHORT COMMUNICATION An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals , 2009 .

[371]  P. Yock,et al.  Intravascular ultrasound: novel pathophysiological insights and current clinical applications. , 2001, Circulation.

[372]  G. Rose,et al.  Strategy of prevention: lessons from cardiovascular disease. , 1981, British medical journal.

[373]  P Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.

[374]  Michal Abrahamowicz,et al.  Cancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarction , 2011, Canadian Medical Association Journal.

[375]  Hans-Georg Beyer,et al.  The Theory of Evolution Strategies , 2001, Natural Computing Series.

[376]  Christina Lindahl,et al.  High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. , 2008, Journal of the American College of Cardiology.

[377]  N Mamelle,et al.  Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. , 1998, Archives of internal medicine.

[378]  Manolis Papadrakakis,et al.  Design optimization of steel structures considering uncertainties , 2005 .

[379]  Undurti N. Das,et al.  Diet, Exercise, and C-Reactive Protein Levels in People With Abdominal Obesity: The ATTICA Epidemiological Study , 2007, Angiology.

[380]  Adrian Thompson,et al.  Evolutionary techniques for fault tolerance , 1996 .

[381]  James O Prochaska,et al.  Stages of change. , 2011, Journal of clinical psychology.

[382]  Satoshi Watanabe,et al.  Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome. , 2008, The American journal of cardiology.

[383]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[384]  Pamela J Schreiner,et al.  Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study. , 2007, Journal of the American College of Cardiology.

[385]  D. Lloyd‐Jones,et al.  Cardiovascular risk prediction: basic concepts, current status, and future directions. , 2010, Circulation.

[386]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[387]  B. Popkin,et al.  Recent dynamics suggest selected countries catching up to US obesity. , 2010, The American journal of clinical nutrition.

[388]  Jennifer G. Robinson,et al.  Management of the Patient with Statin Intolerance , 2010, Current atherosclerosis reports.

[389]  K. Chinnaiyan,et al.  Annual progression of coronary calcification in trials of preventive therapies: a systematic review. , 2009, Archives of internal medicine.

[390]  Giulia Ottaviani,et al.  Perinatal and infant early atherosclerotic coronary lesions. , 2008, The Canadian journal of cardiology.

[391]  Matthew J Budoff,et al.  Coronary calcium remains an effective filter for invasive angiography. , 2010, Journal of the American College of Cardiology.

[392]  J. C. Helton,et al.  Uncertainty and sensitivity analysis in the presence of stochastic and subjective uncertainty , 1997 .

[393]  Xiaoping Du,et al.  A robust design method using variable transformation and Gauss–Hermite integration , 2006 .

[394]  Shigeyoshi Tsutsui,et al.  A comparative study on the effects of adding perturbations to phenotypic parameters in genetic algorithms with a robust solution searching scheme , 1999, IEEE SMC'99 Conference Proceedings. 1999 IEEE International Conference on Systems, Man, and Cybernetics (Cat. No.99CH37028).

[395]  Kemper Lewis,et al.  A comprehensive robust design approach for decision trade-offs in complex systems design , 2001 .

[396]  Salvatore Panico,et al.  Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study. , 2011, European heart journal.

[397]  George A Bray.  Let's treat obesity seriously. , 2010, American family physician.

[398]  Robert O Ryan,et al.  A Two-step Binding Model of PCSK9 Interaction with the Low Density Lipoprotein Receptor* , 2010, The Journal of Biological Chemistry.

[399]  Rodney A Hayward,et al.  Narrative Review: Lack of Evidence for Recommended Low-Density Lipoprotein Treatment Targets: A Solvable Problem , 2006, Annals of Internal Medicine.

[400]  Amy Shui,et al.  Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial , 2006, Circulation.

[401]  Kyung K. Choi,et al.  Integration of Possibility-Based Optimization and Robust Design for Epistemic Uncertainty , 2007 .

[402]  In-Soung Jung,et al.  Robust shape optimization of electromechanical devices , 1999 .

[403]  Jeffrey W. Herrmann,et al.  A genetic algorithm for minimax optimization problems , 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406).

[404]  Paul J. Layzell,et al.  Evolution of Robustness in an Electronics Design , 2000, ICES.

[405]  C. Poole,et al.  Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality , 2007, Heart.

[406]  Harvey S Hecht,et al.  A zero coronary artery calcium score: priceless. , 2010, Journal of the American College of Cardiology.

[407]  J. Witztum,et al.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[408]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[409]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[410]  Yuri M. Ermoliev.  Stochastic Quasigradient Methods , 2009, Encyclopedia of Optimization.

[411]  Harlan M Krumholz,et al.  Shifting views on lipid lowering therapy , 2010, BMJ : British Medical Journal.

[412]  Daniel Steinberg,et al.  Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. , 2008, Circulation.

[413]  Kyung K. Choi,et al.  The Performance Moment Integration Method for Reliability-Based Robust Design Optimization , 2004, DAC 2004.

[414]  Johan P Mackenbach,et al.  Quality of care in stroke prevention: results of an audit study among general practitioners. , 2004, Preventive medicine.

[415]  Kenneth R Feingold,et al.  Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. , 2003, Journal of lipid research.

[416]  G. Coppola,et al.  The predictive role of C‐reactive protein in patients with hypertension and subclinical atherosclerosis , 2009, Internal medicine journal.

[417]  A. Sodickson,et al.  Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. , 2009, Radiology.

[418]  Vijay Nambi,et al.  Utility of statin therapy using high-sensitivity C-reactive protein as an indicator of coronary heart disease risk , 2005, Current atherosclerosis reports.

[419]  J Shepherd,et al.  The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials , 2009, BMJ : British Medical Journal.

[420]  Simon Capewell,et al.  Coronary mortality declines in the U.S. between 1980 and 2000 quantifying the contributions from primary and secondary prevention. , 2010, American journal of preventive medicine.

[421]  Richard Kahn,et al.  The impact of prevention on reducing the burden of cardiovascular disease. , 2008, Circulation.

[422]  Subramaniam Pennathur,et al.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.

[423]  S. Gidding,et al.  Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study , 2008, Circulation.

[424]  Stephen J. Nicholls,et al.  Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. , 2010, Journal of the American College of Cardiology.

[425]  Anders G. Olsson,et al.  Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment , 2008, Circulation.

[426]  C. T. Kelley,et al.  An Implicit Filtering Algorithm for Optimization of Functions with Many Local Minima , 1995, SIAM J. Optim..

[427]  Kenneth Sörensen,et al.  A genetic algorithm for robust schedules in a just-in-time environment , 2002 .

[428]  E. Barrett-Connor,et al.  Association of circulating C-reactive protein and interleukin-6 with longevity into the 80s and 90s: The Rancho Bernardo Study. , 2010, The Journal of clinical endocrinology and metabolism.

[429]  Michael W. Trosset,et al.  Taguchi and Robust Optimization , 1996 .

[430]  Ewout W Steyerberg,et al.  Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. , 2010, Journal of the American College of Cardiology.

[431]  Aldons J Lusis,et al.  Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL , 2004, Journal of Lipid Research.

[432]  A. Rissanen,et al.  Family history as a risk factor of coronary heart disease in patients under 60 years of age. , 1998, European heart journal.

[433]  C. Cannon.  Can the polypill save the world from heart disease? , 2009, The Lancet.

[434]  D R Shapiro,et al.  Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). , 2000, Circulation.

[435]  Moyses Szklo,et al.  Family History of Premature Coronary Heart Disease and Coronary Artery Calcification: Multi-Ethnic Study of Atherosclerosis (MESA) , 2007, Circulation.

[436]  Xiaoping Du,et al.  The use of metamodeling techniques for optimization under uncertainty , 2001 .

[437]  Tom Fahey,et al.  Cardiovascular risk estimation: important but may be inaccurate , 2006, BMJ : British Medical Journal.

[438]  H. Masuzaki,et al.  Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[439]  Victor Kipnis,et al.  Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. , 2007, Archives of internal medicine.

[440]  Stephen Jan,et al.  Global inequalities in access to cardiovascular health care: our greatest challenge. , 2008, Journal of the American College of Cardiology.

[441]  Gerald S. Berenson,et al.  Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study , 1986 .

[442]  Udo Hoffmann,et al.  Diagnostic and prognostic value of absence of coronary artery calcification. , 2009, JACC. Cardiovascular imaging.

[443]  Leslee J Shaw,et al.  Coronary artery calcium to predict all-cause mortality in elderly men and women. , 2008, Journal of the American College of Cardiology.

[444]  D. Lloyd‐Jones,et al.  Biomarkers for coronary heart disease clinical risk prediction: a critical appraisal. Counterpoint. , 2010, Preventive cardiology.

[445]  Shigeyoshi Tsutsui,et al.  Genetic algorithms with a robust solution searching scheme , 1997, IEEE Trans. Evol. Comput..

[446]  Curt D. Furberg,et al.  Lipoprotein Management in Patients With Cardiometabolic Risk , 2008, Diabetes Care.

[447]  W. Kannel,et al.  A general cardiovascular risk profile: the Framingham Study. , 1976, The American journal of cardiology.

[448]  Elinor Miller,et al.  Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). , 2003, The American journal of cardiology.

[449]  Melanie Mitchell,et al.  An introduction to genetic algorithms , 1996 .

[450]  I. Jialal,et al.  The role of the laboratory in the diagnosis of the metabolic syndrome. , 2009, American journal of clinical pathology.

[451]  Yi Zhang,et al.  Enhanced Cellular Uptake of Remnant High-Density Lipoprotein Particles: A Mechanism for High-Density Lipoprotein Lowering in Insulin Resistance and Hypertriglyceridemia , 2008, Circulation research.

[452]  Gerald S. Berenson,et al.  Cardiovascular risk begins in childhood: a time for action. , 2009, American journal of preventive medicine.

[453]  Amy S. Shah,et al.  Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. , 2009, The Journal of clinical endocrinology and metabolism.

[454]  N. Mauras,et al.  Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. , 2010, The Journal of clinical endocrinology and metabolism.

[455]  M. Pencina,et al.  Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. , 2007, JAMA.

[456]  P. Shah,et al.  VIEWPOINT AND COMMENTARY Viewpoint Screening Asymptomatic Subjects for Subclinical Atherosclerosis Can We, Does It Matter, and Should We? , 2022 .

[457]  Stephen D. Persell,et al.  Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey. , 2010, Archives of internal medicine.

[458]  T. Ross.  Fuzzy Logic with Engineering Applications , 1994 .

[459]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[460]  Farrokh Mistree,et al.  Robust Design for Multiscale and Multidisciplinary Applications , 2006 .

[461]  Heinz Drexel,et al.  Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis. , 2010, Atherosclerosis.

[462]  Hanrui Zhang,et al.  Adipose “Talks” to Distant Organs to Regulate Insulin Sensitivity and Vascular Function , 2010, Obesity.

[463]  David M. Reboussin,et al.  A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change , 2010, Diabetes Care.

[464]  Børge G Nordestgaard,et al.  PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. , 2010, Journal of the American College of Cardiology.

[465]  Gerald S Berenson.  Cardiovascular health promotion for children: a model for a Parish (County)-wide program (implementation and preliminary results). , 2010, Preventive cardiology.

[466]  Roger J.-B. Wets.  Modeling and solution strategies for unconstrained stochastic optimization problems , 1984, Ann. Oper. Res..

[467]  Jürgen Branke,et al.  Evolutionary Optimization in Dynamic Environments , 2001, Genetic Algorithms and Evolutionary Computation.

[468]  Vincent J Carey,et al.  Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control. , 2010, The American journal of cardiology.

[469]  D. Weiss,et al.  Inhibition and Genetic Ablation of the B7/CD28 T-Cell Costimulation Axis Prevents Experimental Hypertension , 2010, Circulation.

[470]  Anand Rohatgi,et al.  Separating the contenders from the pretenders: competitive high-throughput biomarker screening in large population-based studies. , 2010, Circulation.

[471]  A. Gotto,et al.  HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. , 2007, The New England journal of medicine.

[472]  Giuseppe Mancia,et al.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document , 2009, Blood pressure.

[473]  D. Bloomfield,et al.  Multiple‐Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects , 2008, Clinical pharmacology and therapeutics.

[474]  J. Heinecke,et al.  The protein cargo of HDL: implications for vascular wall biology and therapeutics. , 2010, Journal of clinical lipidology.

[475]  Laurent El Ghaoui,et al.  Robust Solutions to Least-Squares Problems with Uncertain Data , 1997, SIAM J. Matrix Anal. Appl..

[476]  Qinghong Chen,et al.  Comparing Probabilistic and Fuzzy Set Approaches for Designing in the Presence of Uncertainty , 2000 .

[477]  Stacey L Sheridan,et al.  Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature , 2008, BMC health services research.

[478]  Nikolaus Hansen,et al.  Completely Derandomized Self-Adaptation in Evolution Strategies , 2001, Evolutionary Computation.

[479]  Bernhard Sendhoff,et al.  Evolution Strategies for Robust Optimization , 2006, 2006 IEEE International Conference on Evolutionary Computation.

[480]  P. Heidenreich,et al.  Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol. , 2008, Journal of the American College of Cardiology.

[481]  J. Heinecke,et al.  Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein. , 2010, Chemical research in toxicology.

[482]  D. Miglioretti,et al.  Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. , 2009, Archives of internal medicine.

[483]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.

[484]  Farrokh Mistree,et al.  A procedure for robust design: Minimizing variations caused by noise factors and control factors , 1996 .

[485]  F. A. Campos,et al.  Robust solutions using fuzzy chance constraints , 2006 .

[486]  Kenneth Sörensen,et al.  Tabu Searching for Robust Solutions , 2001 .

[487]  J. Strong,et al.  Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). , 1992, The American journal of cardiology.

[488]  A. Tall,et al.  The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis D.M. is supported by a grant from the Philippe Foundation. Published, JLR Papers in Press, November 20, 2008. , 2009, Journal of Lipid Research.

[489]  Ralph B D'Agostino,et al.  Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.

[490]  J F Cornhill,et al.  Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. , 1999, JAMA.

[491]  Katherine Esposito,et al.  Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. , 2004 .

[492]  Daniel Duprez,et al.  Coronary artery calcification, an improvement in risk classification: need for reappraisal? , 2010, Journal of the American College of Cardiology.

[493]  R. Todd Hurst,et al.  Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis. , 2009, Mayo Clinic proceedings.

[494]  T. Pearson,et al.  The prevention of cardiovascular disease: have we really made progress? , 2007, Health affairs.

[495]  Ralf Klischewski,et al.  Success factors of developing G2G services: the case of Egypt , 2010, ICEGOV '10.

[496]  Dimitris Bertsimas,et al.  A Robust Optimization Approach to Supply Chain Management , 2004, IPCO.

[497]  Claude Lenfant,et al.  ACC/AHA/NHLBI clinical advisory on the use and safety of statins. , 2002, Journal of the American College of Cardiology.

[498]  D. Annane,et al.  Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis , 2004, BMJ : British Medical Journal.

[499]  Kenji Takazawa,et al.  Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[500]  Jennifer G. Robinson,et al.  Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. , 2009, Journal of the American College of Cardiology.

[501]  Imed Boughzala,et al.  eGovernment Trends in the Web 2.0 Era and the Open Innovation Perspective: An Exploratory Field Study , 2011, EGOV.

[502]  Wei Chen,et al.  Local approximation of the efficient frontier in robust design , 2000 .

[503]  Lu Tian,et al.  Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease , 2006, Annals of Internal Medicine.

[504]  Jos F. Sturm,et al.  Robust One-Period Option Hedging , 2006, Oper. Res..

[505]  Anders Larsson,et al.  Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.

[506]  Manolis Papadrakakis,et al.  Reliability based optimization of steel frames under seismic loading conditions using evolutionary computation , 2004 .

[507]  Paul M Ridker,et al.  High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. , 2003, The American journal of cardiology.

[508]  Farzad Mostashari,et al.  Deaths preventable in the U.S. by improvements in use of clinical preventive services. , 2010, American journal of preventive medicine.

[509]  J. Younger,et al.  Family history is important in estimating coronary risk , 2000, BMJ : British Medical Journal.

[510]  Giovanni Amoroso,et al.  Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound. , 2005, American heart journal.

[511]  Nicholas J Wareham,et al.  Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. , 2009, Journal of the American College of Cardiology.

[512]  Thomas Bartz-Beielstein,et al.  Experimental Research in Evolutionary Computation - The New Experimentalism , 2010, Natural Computing Series.

[513]  Simon Capewell,et al.  Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. , 2010, Bulletin of the World Health Organization.

[514]  John R. Birge,et al.  Introduction to Stochastic Programming , 1997 .

[515]  Philippe Giral,et al.  Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. , 2004, The Journal of clinical endocrinology and metabolism.

[516]  Manu Kaushik,et al.  Targeting Residual Risk: The Rationale for the Use of Non-HDL Cholesterol , 2010, Southern medical journal.

[517]  R. Morin,et al.  ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. , 2010, Circulation.

[518]  Jyoti Choudrie,et al.  Evaluating global e-government sites: A view using web diagnostics tools , 2004 .

[519]  Jürgen Branke,et al.  Creating Robust Solutions by Means of Evolutionary Algorithms , 1998, PPSN.

[520]  Lawrence L. Green,et al.  Probabilistic Methods for Uncertainty Propagation Applied to Aircraft Design , 2002 .

[521]  Hiroto Tsujioka,et al.  Multiple coronary lesion instability in patients with acute myocardial infarction as determined by optical coherence tomography. , 2010, The American journal of cardiology.

[522]  S. Reis,et al.  Low Prevalence of “Ideal Cardiovascular Health” in a Community-Based Population: The Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) Study , 2011, Circulation.

[523]  Ephraim R. McLean,et al.  Information Systems Success: The Quest for the Dependent Variable , 1992, Inf. Syst. Res..

[524]  C. Cogbill,et al.  Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? , 2003, Journal of the American College of Cardiology.

[525]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[526]  Sunita Dodani,et al.  Can Conventional Risk Factors Explain Excess Coronary Artery Disease Risk in South Asians: Dyslipidemias and Dysfunctional High Density Lipoprotein (HDL) , 2009 .

[527]  Kees Roos,et al.  Robust Solutions of Uncertain Quadratic and Conic-Quadratic Problems , 2002, SIAM J. Optim..

[528]  M. Pletcher,et al.  Statin therapy in young adults: ready for prime time? , 2010, Journal of the American College of Cardiology.

[529]  Claude Bouchard,et al.  The Pediatric Obesity Epidemic Continues Unabated in Bogalusa, Louisiana , 2010, Pediatrics.

[530]  D. Hajjar,et al.  Inflammation at the molecular interface of atherogenesis: an anthropological journey. , 2008, The American journal of pathology.

[531]  Paul M Ridker,et al.  Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities , 2010, European heart journal.

[532]  D. Atkins,et al.  American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. , 2003, Circulation.

[533]  Emile H. L. Aarts,et al.  Simulated Annealing: Theory and Applications , 1987, Mathematics and Its Applications.

[534]  Timothy W. Simpson,et al.  On the Use of Statistics in Design and the Implications for Deterministic Computer Experiments , 1997 .

[535]  G. Rose,et al.  Alcohol and Drugs: the Scottish Experience , 1993 .

[536]  B. Cheung,et al.  Is intensive LDL-cholesterol lowering beneficial and safe? , 2010, The Lancet.

[537]  John E. Dennis,et al.  Multidirectional search: a direct search algorithm for parallel machines , 1989 .

[538]  Patrizia Toia,et al.  Subclinical atherosclerosis inflammation and events , 2011 .

[539]  Rowena J Dolor,et al.  Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. , 2011, Journal of the American College of Cardiology.

[540]  Jonathan C. Cohen,et al.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.

[541]  Zoran Filipi,et al.  Robust Optimization of an Automotive Valvetrain Using a Multiobjective Genetic Algorithm , 2003, DAC 2003.

[542]  Steven Shea,et al.  Prevalence and Progression of Subclinical Atherosclerosis in Younger Adults With Low Short-Term but High Lifetime Estimated Risk For Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults Study and Multi-Ethnic Study of Atherosclerosis , 2009, Circulation.

[543]  William E. Feeman.  BGS Graph Predicts Better Than the Framingham Risk Score , 2010 .

[544]  B. G. Brown,et al.  Should both HDL-C and LDL-C be targets for lipid therapy? A review of current evidence. , 2007, Journal of clinical lipidology.

[545]  E. Gill,et al.  Carotid intima-media thickness for the practicing lipidologist. , 2010, Journal of clinical lipidology.

[546]  Yasuo Ohashi,et al.  Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial , 2006, The Lancet.

[547]  T J Santner,et al.  Robust optimization of total joint replacements incorporating environmental variables. , 1999, Journal of biomechanical engineering.

[548]  Sankaran Mahadevan,et al.  Inclusion of Model Errors in Reliability-Based Optimization , 2006 .

[549]  N J Wald,et al.  A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.

[550]  Allen J. Taylor,et al.  Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial. , 2011, Journal of the American College of Cardiology.

[551]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[552]  Jennifer G. Robinson,et al.  Are you targeting non-high-density lipoprotein cholesterol? , 2009, Journal of the American College of Cardiology.

[553]  M. de Lorgeril,et al.  Diet as preventive medicine in cardiology. , 2000, Current opinion in cardiology.

[554]  Hans-Paul Schwefel,et al.  Numerical Optimization of Computer Models , 1982 .

[555]  P Michael Ho,et al.  Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. , 2008, American heart journal.

[556]  Michael C. Fu,et al.  Optimization for Simulation: Theory vs. Practice , 2002 .

[557]  Steven Jones,et al.  Should statin therapy be allocated on the basis of global risk or on the basis of randomized trial evidence? , 2010, The American journal of cardiology.

[558]  Alan S. Go,et al.  Population trends in the incidence and outcomes of acute myocardial infarction. , 2010, The New England journal of medicine.

[559]  Wei Chen,et al.  Methodology for Managing the Effect of Uncertainty in Simulation-Based Design , 2000 .

[560]  Donald R. Houser,et al.  A ROBUST OPTIMIZATION PROCEDURE WITH VARIATIONS ON DESIGN VARIABLES AND CONSTRAINTS , 1995 .

[561]  Ralph B D'Agostino,et al.  Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands , 2004, BMJ : British Medical Journal.

[562]  H. Bloomfield,et al.  Low-Density Lipoprotein and High-Density Lipoprotein Particle Subclasses Predict Coronary Events and Are Favorably Changed by Gemfibrozil Therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial , 2006, Circulation.

[563]  Jun S. Liu,et al.  Monte Carlo strategies in scientific computing , 2001 .

[564]  Shirin Rahmani,et al.  Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment , 2003, Circulation.

[565]  C. T. Kelley,et al.  Superlinear Convergence and Implicit Filtering , 1999, SIAM J. Optim..

[566]  B. Goldstein,et al.  Adiponectin: A novel adipokine linking adipocytes and vascular function. , 2004, The Journal of clinical endocrinology and metabolism.

[567]  Gerald Berenson,et al.  Cardiovascular Risk in Young Persons: Secondary or Primordial Prevention? , 2010, Annals of Internal Medicine.

[568]  Kenneth R Feingold,et al.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. , 2004, Journal of lipid research.

[569]  S. D. de Ferranti,et al.  Cardiovascular risk assessment and cholesterol management in adolescents: getting to the heart of the matter , 2010, Current opinion in pediatrics.

[570]  T. Ray.  Constrained robust optimal design using a multiobjective evolutionary algorithm , 2002, Proceedings of the 2002 Congress on Evolutionary Computation. CEC'02 (Cat. No.02TH8600).

[571]  G. Rose,et al.  Strategies of prevention: the individual and the population , 2005 .

[572]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[573]  Takafumi Hiro,et al.  Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[574]  Michael Miller,et al.  Extended-release niacin or ezetimibe and carotid intima-media thickness. , 2009, The New England journal of medicine.

[575]  A. Sharrett,et al.  Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities (ARIC) Study , 2001, Circulation.

[576]  P. Kovanen,et al.  Role of complement activation in atherosclerosis , 2003, Current opinion in lipidology.

[577]  Ranjan Thakur,et al.  Statins and the Reduction of Sudden Cardiac Death , 2010, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[578]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[579]  Harvey S Hecht,et al.  The deadly double standard (the saga of screening for subclinical atherosclerosis). , 2008, The American journal of cardiology.

[580]  Tae Hee Lee,et al.  Robust Design: An Overview , 2006 .

[581]  Deborah A Nickerson,et al.  Soluble P-Selectin, SELP Polymorphisms, and Atherosclerotic Risk in European-American and African-African Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[582]  Robert J. Glynn,et al.  Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial , 2010, Annals of Internal Medicine.

[583]  Gerald S. Berenson,et al.  Autopsy Studies in United States Children and Adolescents a , 1991 .

[584]  J. Heinecke,et al.  HDL and cardiovascular-disease risk--time for a new approach? , 2011, The New England journal of medicine.

[585]  Kenneth A. De Jong,et al.  Genetic Algorithms are NOT Function Optimizers , 1992, FOGA.

[586]  Edward J. Mills,et al.  Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. , 2008, Journal of the American College of Cardiology.

[587]  Diabetes Uk,et al.  JBS 2: Joint British Societies9 guidelines on prevention of cardiovascular disease in clinical practice , 2005 .

[588]  Yin Zhang.  General Robust-Optimization Formulation for Nonlinear Programming , 2007 .

[589]  C. Ballantyne,et al.  Insights from recent meta-analysis: role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression. , 2010, Journal of clinical lipidology.

[590]  R. D'Agostino,et al.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.

[591]  W F ENOS,et al.  Coronary disease among United States soldiers killed in action in Korea; preliminary report. , 1953, Journal of the American Medical Association.

[592]  Robert J Glynn,et al.  The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels. , 2011, Journal of the American College of Cardiology.

[593]  P. Heeringa,et al.  Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2[S] , 2010, Journal of Lipid Research.